Inhibikase Therapeutics Inc (IKT) — Strategic Asset Allocation Index
Inhibikase Therapeutics Inc (IKT) has a Strategic Asset Allocation Index of 2.1% as of March 2023. Strategic assets (PP&E of $534.75K plus long-term investments of $-) total $534.75K, measured against net assets of $25.32 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see how much is Inhibikase Therapeutics Inc worth.
SAAI
Strategic Assets
PP&E
Net Assets
Annual Strategic Asset Allocation Index for Inhibikase Therapeutics Inc (None–None)
The table below presents the year-by-year Strategic Asset Allocation Index for Inhibikase Therapeutics Inc from None to None, covering 0 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore IKT net asset momentum to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|